Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB Cause Liver function test increased? 1,325 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,325 reports of Liver function test increased have been filed in association with RITUXIMAB (Rituxan). This represents 0.7% of all adverse event reports for RITUXIMAB.

1,325
Reports of Liver function test increased with RITUXIMAB
0.7%
of all RITUXIMAB reports
673
Deaths
803
Hospitalizations

How Dangerous Is Liver function test increased From RITUXIMAB?

Of the 1,325 reports, 673 (50.8%) resulted in death, 803 (60.6%) required hospitalization, and 599 (45.2%) were considered life-threatening.

Is Liver function test increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 1,325 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB Cause?

Off label use (39,751) Drug ineffective (32,186) Rheumatoid arthritis (19,850) Pain (16,675) Fatigue (15,602) Arthralgia (12,529) Rash (12,102) Drug intolerance (11,876) Infusion related reaction (11,871) Joint swelling (11,170)

What Other Drugs Cause Liver function test increased?

METHOTREXATE (3,839) ADALIMUMAB (2,070) ETANERCEPT (1,829) LEFLUNOMIDE (1,521) ABATACEPT (1,415) TOCILIZUMAB (1,406) SULFASALAZINE (1,263) HYDROXYCHLOROQUINE (1,259) TOFACITINIB (1,221) INFLIXIMAB (1,191)

Which RITUXIMAB Alternatives Have Lower Liver function test increased Risk?

RITUXIMAB vs RITUXIMAB-ABBS RITUXIMAB vs RITUXIMAB-ARRX RITUXIMAB vs RITUXIMAB-PVVR RITUXIMAB vs RIVAROXABAN RITUXIMAB vs RIVASTIGMINE

Related Pages

RITUXIMAB Full Profile All Liver function test increased Reports All Drugs Causing Liver function test increased RITUXIMAB Demographics